Prandin and Sputum discolored - a phase IV clinical study of FDA data

Summary:

Sputum discolored is found among people who take Prandin, especially for people who are female, 50-59 old.

The phase IV clinical study analyzes which people take Prandin and have Sputum discolored. It is created by eHealthMe based on reports of 4,554 people who have side effects when taking Prandin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

4,554 people reported to have side effects when taking Prandin.
Among them, 9 people (0.2%) have Sputum discolored.

What is Prandin?

Prandin has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 4,620 Prandin users for its effectiveness, alternative drugs and more.

What is Sputum discolored?

Sputum discolored is found to be associated with 1,398 drugs and 494 conditions by eHealthMe.

Number of Prandin and Sputum discolored reports submitted per year:

Gender of people who have Sputum discolored when taking Prandin *:

female: 66.67 %
male: 33.33 %

Age of people who have Sputum discolored when taking Prandin *:

Common drugs people take besides Prandin *:

Common side effects people have besides Sputum discolored *:

Fatigue (feeling of tiredness): 6 people, 66.67%
High Blood Pressure: 5 people, 55.56%
Cataract (clouding of the lens inside the eye): 5 people, 55.56%
Headache (pain in head): 5 people, 55.56%
Nausea And Vomiting: 5 people, 55.56%
Insomnia (sleeplessness): 5 people, 55.56%
Peripheral Swelling: 5 people, 55.56%
Breathing Difficulty: 5 people, 55.56%
Liver Function Tests Nos Abnormal: 4 people, 44.44%
Viral Infection: 4 people, 44.44%

Common conditions people have *:

Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina): 5 people, 55.56%

* Approximation only. Some reports may have incomplete information.

Do you take Prandin and have Sputum discolored?

Check whether Sputum discolored is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Sputum discolored and when was it recovered:

Sputum discolored in Prandin

Expand to all the drugs that have ingredients of repaglinide:

Sputum discolored and drugs with ingredients of repaglinide

Alternative drugs to, pros and cons of Prandin:

Prandin (4,620 reports)

Common Prandin side effects:

Weight decreased: 399 reports
Fatigue (feeling of tiredness): 326 reports
Diarrhea: 283 reports
Pain: 275 reports
Weakness: 269 reports

Browse all side effects of Prandin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sputum discolored treatments and more:

Sputum discolored (11,316 reports)

COVID vaccines that are related to Sputum discolored:

Common drugs associated with Sputum discolored:

How the study uses the data?

The study uses data from the FDA. It is based on repaglinide (the active ingredients of Prandin) and Prandin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.